Previous Close | 0.0000 |
Open | 0.0233 |
Bid | 0.0200 x 0 |
Ask | 0.0219 x 0 |
Day's Range | 0.0223 - 0.0233 |
52 Week Range | 0.0210 - 0.0950 |
Volume | |
Avg. Volume | 0 |
Market Cap | 4.333M |
Beta (5Y Monthly) | 1.08 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0100 |
Earnings Date | Sept 16, 2024 - Sept 17, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
LONDON, Ontario, June 13, 2024--Indiva Limited ("Indiva") (TSXV:NDVA) announced today that Indiva and its subsidiaries (collectively, the "Indiva Group") have been granted an order (the "Initial Order") from the Ontario Superior Court of Justice (Commercial List) (the "Court") under the Companies’ Creditors Arrangement Act (the "CCAA"), in order to restructure their business and financial affairs.
LONDON, Ontario, June 03, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to provide an update to the information contained in its press release dated April 2, 2024. As discussed in the prior press release, the Company: (i) entered into an amendment (the "Amending Agreement") to the second amended and restated promissory note (the "Promissory Note") between, among others, the Company and SNDL Inc. ("SNDL"), whereby, amon
LONDON, Ontario, May 23, 2024--Indiva Limited (the "Company" or "Indiva") (TSXV:NDVA), the leading Canadian producer of cannabis edibles, is pleased to announce its financial and operating results for the first fiscal quarter ended March 31, 2024. All figures are reported in Canadian dollars ($), unless otherwise indicated. Indiva's financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS"). For a more comprehensive overview of the corporate and fin